St. Johns Investment Management Company, LLC Gilead Sciences, Inc. Transaction History

St. Johns Investment Management Company, LLC

$213 Million
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 22, 2018	SELL	$71.28 - $78.92 $35,640 - $39,460	-500 Closed	0 $0
Q2 2018 Jul 18, 2018	SELL	$64.88 - $75.68 $294,620 - $343,662	-4,541 Reduced 90.08%	500 $35,000
Q1 2018 May 03, 2018	BUY	$72.84 - $88.8 $2,403 - $2,930	33 Added 0.66%	5,041 $380,000
Q4 2017 Jan 16, 2018	BUY	$71.15 - $83.52 $15,724 - $18,457	221 Added 4.62%	5,008 $359,000
Q3 2017 Oct 17, 2017	BUY	$72.11 - $85.47 $345,190 - $409,144	4,787	4,787 $388,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of St. Johns Investment Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on St. Johns Investment Management Company, LLC with notifications on news.

Account